Close Menu

NEW YORK — HTG Molecular Diagnostics said Monday that it expects to report a nearly 11 percent year-over-year drop in revenues for 2019.

According to the Tuscon, Arizona-based company, total revenues for 2019 are expected to be $19.2 million compared with $21.5 million in 2018. On average, analysts are expecting HTG to report 2019 revenues of approximaltely $19.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.